{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:54:38Z","timestamp":1779886478407,"version":"3.53.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["300906"],"award-info":[{"award-number":["300906"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Foundation, UK","award":["1725841"],"award-info":[{"award-number":["1725841"]}]},{"name":"Health Foundation, UK","award":["1725841"],"award-info":[{"award-number":["1725841"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acute myocardial infarction (AMI) causes significant mortality and morbidity in people with impaired kidney function. Previous observational research has demonstrated reduced use of invasive management strategies and inferior outcomes in this population. Studies from the USA have suggested that disparities in care have reduced over time. It is unclear whether these findings extend to Europe and the UK.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Linked data from four national healthcare datasets were used to investigate management and outcomes of AMI by estimated glomerular filtration rate (eGFR) category in England. Multivariable logistic and Cox regression models compared management strategies and outcomes by eGFR category among people with kidney impairment hospitalised for AMI between 2015\u20132017.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In a cohort of 5 835 people, we found reduced odds of invasive management in people with eGFR\u2009&lt;\u200960mls\/min\/1.73m<jats:sup>2<\/jats:sup> compared with people with eGFR\u2009\u2265\u200960 when hospitalised for non-ST segment elevation MI (NSTEMI). The association between eGFR and odds of invasive management for ST-elevation MI (STEMI) varied depending on the availability of percutaneous coronary intervention. A graded association between mortality and eGFR category was demonstrated both in-hospital and after discharge for all people.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In England, patients with reduced eGFR are less likely to receive invasive management compared to those with preserved eGFR. Disparities in care may however be decreasing over time, with the least difference seen in patients with STEMI managed via the primary percutaneous coronary intervention pathway. Reduced eGFR continues to be associated with worse outcomes after AMI.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-023-03377-x","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T18:02:53Z","timestamp":1698948173000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Management and outcomes of myocardial infarction in people with impaired kidney function in England"],"prefix":"10.1186","volume":"24","author":[{"given":"Jemima","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Bidulka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic M.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udaya","family":"Udayaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergus J.","family":"Caskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Birnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Deanfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"de Belder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiros","family":"Denaxas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Weston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Adlam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Nitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"issue":"7","key":"3377_CR1","doi-asserted-by":"publisher","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, Hirst JAO, Callaghan CA, Lasserson DS, Hobbs FDR. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765.","journal-title":"PLoS One"},{"issue":"9","key":"3377_CR2","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/heart.89.9.1003","volume":"89","author":"JJ Santopinto","year":"2003","unstructured":"Santopinto JJ, Fox KA, Goldberg RJ, Budaj A, Pinero G, Avezum A, et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart (British Cardiac Society). 2003;89(9):1003\u20138.","journal-title":"Heart (British Cardiac Society)"},{"issue":"6","key":"3377_CR3","doi-asserted-by":"publisher","first-page":"e008188","DOI":"10.1136\/bmjopen-2015-008188","volume":"5","author":"S Sederholm Lawesson","year":"2015","unstructured":"Sederholm Lawesson S, Alfredsson J, Szummer K, Fredrikson M, Swahn E. Prevalence and prognostic impact of chronic kidney disease in STEMI from a gender perspective: data from the SWEDEHEART register, a large Swedish prospective cohort. BMJ Open. 2015;5(6):e008188.","journal-title":"BMJ Open"},{"issue":"1","key":"3377_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ahj.2012.04.009","volume":"164","author":"EB Hanna","year":"2012","unstructured":"Hanna EB, Chen AY, Roe MT, Saucedo JF. Characteristics and in-hospital outcomes of patients presenting with non-ST-segment elevation myocardial infarction found to have significant coronary artery disease on coronary angiography and managed medically: stratification according to renal function. Am Heart J. 2012;164(1):52-7.e1.","journal-title":"Am Heart J"},{"issue":"3","key":"3377_CR5","doi-asserted-by":"publisher","first-page":"e0192895","DOI":"10.1371\/journal.pone.0192895","volume":"13","author":"RW Major","year":"2018","unstructured":"Major RW, Cheng MRI, Grant RA, Shantikumar S, Xu G, Oozeerally I, et al. Cardiovascular disease risk factors in chronic kidney disease: a systematic review and meta-analysis. PLoS ONE. 2018;13(3):e0192895.","journal-title":"PLoS ONE"},{"issue":"24","key":"3377_CR6","doi-asserted-by":"publisher","first-page":"e010394","DOI":"10.1161\/JAHA.118.010394","volume":"7","author":"A Bagai","year":"2018","unstructured":"Bagai A, Lu D, Lucas J, Goyal A, Herzog CA, Wang TY, et al. Temporal trends in utilization of cardiac therapies and outcomes for myocardial infarction by degree of chronic kidney disease: a report from the NCDR chest pain-MI registry. J Am Heart Assoc. 2018;7(24):e010394.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"3377_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1159\/000363616","volume":"37","author":"S Jakobsson","year":"2014","unstructured":"Jakobsson S, Graipe A, Huber D, Bjorklund F, Mooe T. The risk of ischemic stroke after an acute myocardial infarction in patients with decreased renal function. Cerebrovasc Dis. 2014;37(6):460\u20139.","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"3377_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1001\/jamainternmed.2015.6102","volume":"176","author":"I Konstantinidis","year":"2016","unstructured":"Konstantinidis I, Nadkarni GN, Yacoub R, Saha A, Simoes P, Parikh CR, et al. Representation of patients with kidney disease in trials of cardiovascular interventions: an updated systematic review. JAMA Intern Med. 2016;176(1):121\u20134.","journal-title":"JAMA Intern Med"},{"issue":"10","key":"3377_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.108.838169","volume":"120","author":"K Szummer","year":"2009","unstructured":"Szummer K, Lundman P, Jacobson SH, Schon S, Lindback J, Stenestrand U, et al. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation. 2009;120(10):851\u20138.","journal-title":"Circulation"},{"issue":"3","key":"3377_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.109.865352","volume":"121","author":"CS Fox","year":"2010","unstructured":"Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Cannon CP, et al. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the national cardiovascular data acute coronary treatment and intervention outcomes network registry. Circulation. 2010;121(3):357\u201365.","journal-title":"Circulation"},{"issue":"6","key":"3377_CR11","doi-asserted-by":"publisher","first-page":"e007920","DOI":"10.1161\/JAHA.117.007920","volume":"7","author":"S Bhatia","year":"2018","unstructured":"Bhatia S, Arora S, Bhatia SM, Al-Hijji M, Reddy YNV, Patel P, et al. Non-ST-segment-elevation myocardial infarction among patients with chronic kidney disease: a propensity score-matched comparison of percutaneous coronary intervention versus conservative management. J Am Heart Assoc. 2018;7(6):e007920.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"3377_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0002-9149(03)00716-1","volume":"92","author":"EC Keeley","year":"2003","unstructured":"Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol. 2003;92(5):509\u201314.","journal-title":"Am J Cardiol"},{"issue":"6","key":"3377_CR13","doi-asserted-by":"publisher","first-page":"e99925","DOI":"10.1371\/journal.pone.0099925","volume":"9","author":"C Shaw","year":"2014","unstructured":"Shaw C, Nitsch D, Steenkamp R, Junghans C, Shah S, O\u2019Donoghue D, et al. Inpatient coronary angiography and revascularisation following non-ST-elevation acute coronary syndrome in patients with renal impairment: a cohort study using the myocardial ischaemia national audit project. PLoS ONE. 2014;9(6):e99925.","journal-title":"PLoS ONE"},{"key":"3377_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.kint.2022.02.019","volume":"102","author":"PJ Gallacher","year":"2022","unstructured":"Gallacher PJ, Miller-Hodges E, Shah ASV, Farrah TE, Halbesma N, Blackmur JP, et al. High-sensitivity cardiac troponin and the diagnosis of myocardial infarction in patients with kidney impairment. Kidney Int. 2022;102:149\u201359.","journal-title":"Kidney Int"},{"issue":"6","key":"3377_CR15","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1053\/j.ajkd.2021.08.023","volume":"79","author":"A Kawsara","year":"2022","unstructured":"Kawsara A, Sulaiman S, Mohamed M, Paul TK, Kashani KB, Boobes K, et al. Treatment effect of percutaneous coronary intervention in dialysis patients with ST-elevation myocardial infarction. Am J Kidney Dis. 2022;79(6):832\u201340.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"3377_CR16","first-page":"e4","volume":"145","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(3):e4\u201317.","journal-title":"Circulation"},{"issue":"6","key":"3377_CR17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.recesp.2020.12.024","volume":"74","author":"JP Collet","year":"2021","unstructured":"Collet JP, Thiele H, Barbato E, Barth\u00e9l\u00e9my O, Bauersachs J, Bhatt DL, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Rev Esp Cardiol (Engl Ed). 2021;74(6):544.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"2","key":"3377_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ki.2013.71","volume":"84","author":"ST Nauta","year":"2013","unstructured":"Nauta ST, van Domburg RT, Nuis RJ, Akkerhuis M, Deckers JW. Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention era. Kidney Int. 2013;84(2):353\u20138.","journal-title":"Kidney Int"},{"key":"3377_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.amjcard.2021.03.057","volume":"150","author":"HB Panchal","year":"2021","unstructured":"Panchal HB, Zheng S, Devani K, White CJ, Leinaar EF, Mukherjee D, et al. Impact of chronic kidney disease on revascularization and outcomes in patients with ST-elevation myocardial infarction. Am J Cardiol. 2021;150:15\u201323.","journal-title":"Am J Cardiol"},{"issue":"12","key":"3377_CR20","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.carrev.2020.05.004","volume":"21","author":"MZ Khan","year":"2020","unstructured":"Khan MZ, Syed M, Osman M, Faisaluddin M, Sulaiman S, Farjo PD, et al. Contemporary trends and outcomes in patients with ST-segment elevation myocardial infarction and end-stage renal disease on dialysis: insight from the national inpatient sample. Cardiovasc Revasc Med. 2020;21(12):1474\u201381.","journal-title":"Cardiovasc Revasc Med"},{"key":"3377_CR21","unstructured":"The DH Vascular Programme Team. Treatment of heart attack national guidance: final report of the National Infarct Angioplasty Project (NIAP).\u00a0London: Department of Health; 2008."},{"issue":"3","key":"3377_CR22","doi-asserted-by":"publisher","first-page":"e057909","DOI":"10.1136\/bmjopen-2021-057909","volume":"12","author":"P Bidulka","year":"2022","unstructured":"Bidulka P, Scott J, Taylor DM, Udayaraj U, Caskey F, Teece L, et al. Impact of chronic kidney disease on case ascertainment for hospitalised acute myocardial infarction: an English cohort study. BMJ Open. 2022;12(3):e057909.","journal-title":"BMJ Open"},{"key":"3377_CR23","doi-asserted-by":"publisher","first-page":"f2350","DOI":"10.1136\/bmj.f2350","volume":"346","author":"E Herrett","year":"2013","unstructured":"Herrett E, Shah AD, Boggon R, Denaxas S, Smeeth L, van Staa T, et al. Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study. BMJ. 2013;346:f2350.","journal-title":"BMJ"},{"key":"3377_CR24","unstructured":"Nitsch D CB HS, Wheeler D. National chronic kidney disease audit - national report part 1; 2017."},{"key":"3377_CR25","unstructured":"Mudie K CF CB, Wheeler D, Hull S, Nitsch D. National chronic kidney disease audit: national report part 2; 2017."},{"key":"3377_CR26","unstructured":"Statistics HE. Hospital Episode Statistics (HES); 2022. Available from: https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/hospital-episode-statistics."},{"key":"3377_CR27","unstructured":"NICOR. Myocardial Ischaemia\/MINAP (Heart Attack audit); 2022. Available from: https:\/\/www.nicor.org.uk\/myocardial-ischaemia-minap-heart-attack-audit\/."},{"issue":"16","key":"3377_CR28","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1136\/hrt.2009.192328","volume":"96","author":"E Herrett","year":"2010","unstructured":"Herrett E, Smeeth L, Walker L, Weston C. The Myocardial Ischaemia National Audit Project (MINAP). Heart. 2010;96(16):1264\u20137.","journal-title":"Heart"},{"key":"3377_CR29","unstructured":"Statistics OfN. Office for National Statistics, Census 2021. Deaths. Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths.\u00a0Accessed 6 Jan 2022."},{"key":"3377_CR30","unstructured":"Gov.uk. English Indices of Deprivation 2019; 2019. Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths."},{"issue":"6","key":"3377_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130(6):461\u201370.","journal-title":"Ann Intern Med"},{"issue":"1","key":"3377_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2010.483","volume":"80","author":"AS Levey","year":"2011","unstructured":"Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80(1):17\u201328.","journal-title":"Kidney Int"},{"issue":"1","key":"3377_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/jama.2018.6971","volume":"320","author":"EC Norton","year":"2018","unstructured":"Norton EC, Dowd BE, Maciejewski ML. Odds ratios-current best practice and use. JAMA. 2018;320(1):84\u20135.","journal-title":"JAMA"},{"issue":"5","key":"3377_CR34","doi-asserted-by":"publisher","first-page":"e0153478","DOI":"10.1371\/journal.pone.0153478","volume":"11","author":"C Shaw","year":"2016","unstructured":"Shaw C, Nitsch D, Lee J, Fogarty D, Sharpe CC. Impact of an early invasive strategy versus conservative strategy for unstable angina and non-ST elevation acute coronary syndrome in patients with chronic kidney disease: a systematic review. PLoS ONE. 2016;11(5):e0153478.","journal-title":"PLoS ONE"},{"issue":"6","key":"3377_CR35","doi-asserted-by":"publisher","first-page":"7920","DOI":"10.1161\/JAHA.117.007920","volume":"7","author":"S Bhatia","year":"2018","unstructured":"Bhatia S, Arora S, Bhatia SM, Al-Hijji M, Reddy YN, Patel P, et al. Non-ST-segment-elevation myocardial infarction among patients with chronic kidney disease: a propensity score-matched comparison of percutaneous coronary intervention versus conservative management. J Am Heart Assoc. 2018;7(6):7920.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"3377_CR36","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1080\/08998280.2017.11930205","volume":"30","author":"B Patel","year":"2017","unstructured":"Patel B, Shah M, Dusaj R, Maynard S, Patel N. Percutaneous coronary intervention and inpatient mortality in patients with advanced chronic kidney disease presenting with acute coronary syndrome. Proc (Baylor Univ Med Cent). 2017;30(4):400\u20133.","journal-title":"Proc (Baylor Univ Med Cent)"},{"issue":"10","key":"3377_CR37","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.jacc.2015.11.065","volume":"67","author":"PA McCullough","year":"2016","unstructured":"McCullough PA, Roberts WC. Influence of chronic renal failure on cardiac structure. J Am Coll Cardiol. 2016;67(10):1183\u20135.","journal-title":"J Am Coll Cardiol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03377-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03377-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03377-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T18:03:20Z","timestamp":1698948200000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03377-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3377"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03377-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"10 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. This study was approved by the London School of Hygiene & Tropical Medicine LEO ethics committee (ID 16988) and the National Chronic Kidney Disease Audit (NCKDA) Steering Committee. Audits used in this study are covered by Section 251 approvals (NHS Act 2006) which allows data to be collected without individual patient consent for medical research when it is not possible to use anonymised information and when seeking consent is not practical.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have completed an ICJME form. PB, DMT, FJC, KB, MDB, and SD have nothing to declare. UU declares a grant from the Health Foundation to undertake quality improvement unrelated to this work. MS declares funding from Cancer Research UK (C53325\/A21134) and British Heart Foundation (SP\/16\/5\/32415) for research activities related to this work looking at acute myocardial infarction ascertainment in a cancer population. JS declares Doctoral research funding from the NIHR for related research looking at acute myocardial infarction care for people with chronic kidney disease. JD declares grants from British Heart Foundation paid to his institution unrelated to this work. JD also declares consulting fees from Novo Nordisk, and honoraria from Amgen, Boehringer Ingelheim, Merck, Pfizer, Aegerion, Novartis, Sanofi, Takeda, Novo Nordisk, and Bayer, unrelated to this work. JD is also member of a study steering committee with Novo Nordisk. CW declares he is clinical lead of the Myocardial Ischaemia National Audit Project. DA reports research funding and in-kind support from Astra Zeneca inc. for unrelated research and educational funding from Abbott Vascular inc. to support a clinical research fellow doing unrelated research. DA has conducted consultancy for General Electric inc. to support general research funds. DN is the UK Kidney Association Director of Informatics Research. DN is also on the steering group for two GlaxoSmithKline funded studies that investigate kidney function in children and adults in Sub-Saharan Africa.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"325"}}